SWA
TMO icon

Stratos Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Stratos Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Buy
2,316
+199
+9% +$108K 0.07% 256
2025
Q4 		$1.23M Sell
2,117
-309
-13% -$175K 0.06% 284
2025
Q3 		$1.18M Buy
2,426
+20
+0.8% +$9.31K 0.06% 294
2025
Q2 		$976K Buy
2,406
+79
+3% +$33K 0.05% 319
2025
Q1 		$1.16M Sell
2,327
-1,468
-39% -$795K 0.06% 280
2024
Q4 		$1.97M Buy
3,795
+14
+0.4% +$7.7K 0.09% 219
2024
Q3 		$2.34M Buy
3,781
+45
+1% +$26.6K 0.11% 204
2024
Q2 		$2.07M Sell
3,736
-37
-1% -$21.2K 0.1% 204
2024
Q1 		$2.19M Buy
3,773
+128
+4% +$71.8K 0.13% 184
2023
Q4 		$1.94M Sell
3,645
-550
-13% -$266K 0.11% 228
2023
Q3 		$2.12M Buy
4,195
+1,338
+47% +$713K 0.14% 192
2023
Q2 		$1.49M Buy
2,857
+234
+9% +$126K 0.11% 233
2023
Q1 		$1.51M Sell
2,623
-100
-4% -$56.4K 0.12% 223
2022
Q4 		$1.5M Buy
2,723
+1,100
+68% +$583K 0.13% 224
2022
Q3 		$823K Buy
1,623
+243
+18% +$136K 0.09% 271
2022
Q2 		$750K Buy
1,380
+40
+3% +$22K 0.07% 300
2022
Q1 		$792K Buy
1,340
+448
+50% +$257K 0.06% 311
2021
Q4 		$596K Buy
892
+10
+1% +$6.24K 0.04% 364
2021
Q3 		$504K Sell
882
-623
-41% -$342K 0.04% 354
2021
Q2 		$759K Buy
1,505
+229
+18% +$108K 0.07% 280
2021
Q1 		$582K Buy
1,276
+503
+65% +$240K 0.06% 294
2020
Q4 		$360K Sell
773
-8
-1% -$3.75K 0.05% 293
2020
Q3 		$345K Sell
781
-258
-25% -$107K 0.08% 230
2020
Q2 		$377K Buy
1,039
+246
+31% +$82.5K 0.12% 175
2020
Q1 		$225K Sell
793
-125
-14% -$39.4K 0.16% 131
2019
Q4 		$298K Sell
918
-1,825
-67% -$553K 0.17% 131
2019
Q3 		$799K Sell
2,743
-87
-3% -$24.9K 0.31% 84
2019
Q2 		$831K Buy
2,830
+84
+3% +$23.1K 0.33% 71
2019
Q1 		$752K Sell
2,746
-43
-2% -$10.7K 0.41% 65
2018
Q4 		$624K Buy
+2,789
New +$654K 0.42% 69

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stratos Wealth Advisors's TMO Position: Q1 2026 in Review

Stratos Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 9.4% in Q1 2026, buying an estimated $108K and bringing the position to 2,316 shares worth $1.14M. The position accounts for 0.07% of the portfolio, ranked #256.

Stratos Wealth Advisors first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.34M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Stratos Wealth Advisors held 2,316 shares of Thermo Fisher Scientific worth $1.14M as of Q1 2026.
  • Stratos Wealth Advisors bought 199 Thermo Fisher Scientific shares in Q1 2026, an estimated $108K.
  • Thermo Fisher Scientific made up 0.07% of Stratos Wealth Advisors's portfolio in Q1 2026, its #256 holding.
  • Stratos Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Stratos Wealth Advisors's Thermo Fisher Scientific position peaked at $2.34M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.